JBTM Strangle Strategy
JBTM (JBT Marel Corporation), in the Industrials sector, (Industrial - Machinery industry), listed on NYSE.
JBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market. In addition, it offers automated guided vehicle systems for material movement in the manufacturing, warehouse, and medical facilities. It serves baby food, bakery and confectionery, citrus processing, fruits and nuts, juices, non-food, pet food, pharmaceutical, plant- based beverages and protein, poultry, meat, and seafood, ready meals, oils, soups, sauces, seasoning and dressings, automotive, building material, tissue, paper, and packaging, hospitals, pharma and life sciences, fast moving consumer goods, manufacturing, warehousing, and other industries. The company markets and sells its products and solutions through direct sales force, independent distributors, sales representatives, and technical service teams. The company was formerly known as John Bean Technologies Corporation and changed its name to JBT Marel Corporation in January 2025.
JBTM (JBT Marel Corporation) trades in the Industrials sector, specifically Industrial - Machinery, with a market capitalization of approximately $6.51B, a trailing P/E of 38.99, a beta of 0.92 versus the broader market, a 52-week range of 111.07-170.19, average daily share volume of 610K, a public-listing history dating back to 2008, approximately 12K full-time employees. These structural characteristics shape how JBTM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.92 places JBTM roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 38.99 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. JBTM pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on JBTM?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current JBTM snapshot
As of May 15, 2026, spot at $125.38, ATM IV 43.60%, IV rank 37.74%, expected move 12.50%. The strangle on JBTM below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on JBTM specifically: JBTM IV at 43.60% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 12.50% (roughly $15.67 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated JBTM expiries trade a higher absolute premium for lower per-day decay. Position sizing on JBTM should anchor to the underlying notional of $125.38 per share and to the trader's directional view on JBTM stock.
JBTM strangle setup
The JBTM strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With JBTM near $125.38, the first option leg uses a $130.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed JBTM chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 JBTM shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $130.00 | $4.95 |
| Buy 1 | Put | $120.00 | $4.05 |
JBTM strangle risk and reward
- Net Premium / Debit
- -$900.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$900.00
- Breakeven(s)
- $111.00, $139.00
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
JBTM strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on JBTM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$11,099.00 |
| $27.73 | -77.9% | +$8,326.89 |
| $55.45 | -55.8% | +$5,554.78 |
| $83.17 | -33.7% | +$2,782.67 |
| $110.89 | -11.6% | +$10.56 |
| $138.62 | +10.6% | -$38.45 |
| $166.34 | +32.7% | +$2,733.66 |
| $194.06 | +54.8% | +$5,505.77 |
| $221.78 | +76.9% | +$8,277.88 |
| $249.50 | +99.0% | +$11,049.99 |
When traders use strangle on JBTM
Strangles on JBTM are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the JBTM chain.
JBTM thesis for this strangle
The market-implied 1-standard-deviation range for JBTM extends from approximately $109.71 on the downside to $141.05 on the upside. A JBTM long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current JBTM IV rank near 37.74% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on JBTM should anchor more to the directional view and the expected-move geometry. As a Industrials name, JBTM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to JBTM-specific events.
JBTM strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. JBTM positions also carry Industrials sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move JBTM alongside the broader basket even when JBTM-specific fundamentals are unchanged. Always rebuild the position from current JBTM chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on JBTM?
- A strangle on JBTM is the strangle strategy applied to JBTM (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With JBTM stock trading near $125.38, the strikes shown on this page are snapped to the nearest listed JBTM chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are JBTM strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the JBTM strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 43.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$900.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a JBTM strangle?
- The breakeven for the JBTM strangle priced on this page is roughly $111.00 and $139.00 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current JBTM market-implied 1-standard-deviation expected move is approximately 12.50%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on JBTM?
- Strangles on JBTM are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the JBTM chain.
- How does current JBTM implied volatility affect this strangle?
- JBTM ATM IV is at 43.60% with IV rank near 37.74%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.